Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Revive Therapeutics Ltd C.RVV

Alternate Symbol(s):  RVVTF

Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders. It is engaged in exploring the use of Bucillamine for the potential treatment of nerve agent exposure and long COVID. The Company, through its diagnostics division, is evaluating a point-of-care in vitro diagnostic device that aids in the detection of post COVID-19 conditions or Long COVID. It also advancing the development of Psilocybin-based therapeutics through various programs. The Company's subsidiaries include Revive Therapeutics Inc. (Ontario), Revive Diagnostics Inc., and Psilocin Pharma Corp. (Ontario).


CSE:RVV - Post by User

Bullboard Posts
Comment by Bella2017on Jul 15, 2017 4:21am
88 Views
Post# 26472297

RE:RE:RE:RE:RE:L2

RE:RE:RE:RE:RE:L2Same here Derek, this is the way I see it..mother nature gave us a plant that's been around for thousands of years, science has been working on it for quite some time, more than they tell us, and as of the recent years everyone is jumping on the wagon, be it for medical or recreational it's happening in our lifetime.. If I was a scientist, doctor ect, I would be jumping on it too.. end result, this will explode and in a good way. Best part of it, people with serious health conditions will get relief, cures and so on.Us making money is secondary. Big pharma will want the whole pie...patients will stop taking all those meds and move on to medical marijauna. It's inevitable. 


Just a little patience..  :)






DerekVTX wrote: I certianily will be holding out for the anticipated announcements that we can all hope will come to light. I am no expert but my guess is that there may be some accumulation going on here.  Small market cap is also a plus at under 10 million, and there is a big potiental here for a huge proft with these products.  Potential buy out from big Pharma. 


Bullboard Posts